Therapies for dactylitis in psoriatic arthritis. A systematic review.

Author: HelliwellPhilip S

Paper Details 
Original Abstract of the Article :
Dactylitis is a hallmark clinical feature of psoriatic arthritis (PsA). Acute dactylitis appears to be a severity marker for PsA and psoriasis. Traditionally, clinicians have used nonsteroidal antiinflammatory rheumatic drugs and local corticosteroid injections to treat dactylitis, although conventi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/16724369

データ提供:米国国立医学図書館(NLM)

Dactylitis in Psoriatic Arthritis: A Need for Effective Treatments

Psoriatic arthritis (PsA) is a chronic inflammatory disease characterized by joint pain and swelling, often accompanied by dactylitis, a painful inflammation of the fingers and toes. This systematic review examines the limited data on treatments for dactylitis in PsA, highlighting the need for effective therapeutic approaches.

Limited Data on Dactylitis Treatments

The review found limited evidence on the effectiveness of various treatments for dactylitis in PsA. While traditional treatments like nonsteroidal antiinflammatory drugs and corticosteroid injections are often used, the review suggests that infliximab is the only drug showing significant improvement in dactylitis during clinical studies. This highlights the need for further research to identify effective and safe treatments for dactylitis in PsA.

Improving Dactylitis Treatment in Psoriatic Arthritis

This research underscores the importance of developing more effective treatments for dactylitis in PsA. The lack of robust data emphasizes the need for further research, focusing on identifying new drugs and therapeutic approaches that can alleviate the pain and disability associated with dactylitis. This would significantly improve the quality of life for individuals with PsA.

Dr. Camel's Conclusion

The study's findings emphasize the importance of addressing dactylitis in PsA. Just as a camel navigates the desert, we must seek innovative solutions for managing this painful and debilitating condition. Further research is crucial to develop effective therapies for dactylitis in PsA, improving the lives of those affected by this challenging disease.

Date :
  1. Date Completed 2006-11-07
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

16724369

DOI: Digital Object Identifier

06/13/0514

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.